North Coast Technology Investors, established in 1998 and based in Ann Arbor, Michigan, is a venture capital firm specializing in early-stage technology companies across the United States, particularly in the software and communications sectors. The firm is known for its ability to support promising ventures through all stages of their private funding needs. While North Coast often collaborates with other venture capital firms and corporate partners, it frequently acts as the first or sole investor in the companies it chooses to back. This approach allows North Coast to play a significant role in nurturing innovative technology enterprises.
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
BetterWorks
Series B in 2019
Betterworks is a leading provider of intelligent performance management software aimed at enhancing workforce effectiveness and engagement. Its enterprise-ready SaaS platform equips organizations with essential tools for continuous performance management, including goal alignment, feedback mechanisms, coaching, and employee recognition. By integrating generative AI and data analytics, Betterworks enables companies to make informed, data-driven decisions regarding performance management, skill development, and career progression. The platform facilitates meaningful manager-employee interactions and captures both structured and unstructured data, offering HR professionals comprehensive insights into employee performance. This holistic approach not only supports employee growth and retention but also drives overall business success by fostering a motivated and aligned workforce across various organizational levels.
BlueWillow Biologics
Series A in 2018
BlueWillow Biologics, a clinical-stage biopharmaceutical company based in Ann Arbor, Michigan, specializes in the development of intranasal vaccines and anti-infective products utilizing its patented nanotechnology platform. The company's innovative NanoStat vaccine technology incorporates a unique oil-in-water nanoemulsion, allowing for the effective delivery and adjuvant of various antigens. BlueWillow focuses on vaccines for respiratory and sexually transmitted diseases, including pertussis, pandemic influenza, anthrax, and HIV, as well as providing NanoBio Protect, a nasal antiseptic solution. The company also has a licensing agreement with Merck for the use of its adjuvant in intranasal vaccines for respiratory syncytial virus (RSV) and seasonal influenza. Founded in 1999 as a spin-off from the University of Michigan, BlueWillow Biologics aims to enhance mucosal immunity through its advanced vaccine technology.
Impact Analytical
Venture Round in 2017
Impact Analytical is a contract testing laboratory that specializes in supporting various industries, including pharmaceuticals, consumer products, medical devices, plastics, specialty chemicals, and automotive. With over 30 years of experience in polymer and chemistry analysis, the company offers a comprehensive range of services, such as method development, validation, stability testing, extractables and leachables analysis, and failure analysis. Impact Analytical is recognized for its commitment to quality, being GMP registered, GLP compliant, ISO 9001 certified, and DEA licensed. The laboratory is routinely audited by the FDA, consistently maintaining compliance without findings. Their focus on customer satisfaction ensures that clients receive timely and accurate results for both short-term sample analyses and long-term research projects, enhancing laboratory testing capabilities across multiple domains.
AmpliFund
Series A in 2016
AmpliFund provides a cloud-based grant management software solution that serves both grant makers and grant seekers, facilitating the entire grant life-cycle. The platform enables users to streamline processes, centralize data and documentation, and enhance both quantitative and qualitative reporting. By automating various activities throughout the grant management process, AmpliFund drives standardization, efficiency, transparency, and compliance, which are crucial for accountability in grant program outcomes. Founded by professionals with expertise in grant management, the company focuses on empowering state, local, and tribal governments to maximize their funding potential and create capacity within their teams. Through its innovative tools and resources, AmpliFund aims to simplify business processes and amplify grant resources to support impactful missions.
Delphinus Medical Technologies
Series C in 2015
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
VNN
Venture Round in 2015
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.
Larky
Series A in 2014
Larky, Inc. is a marketing and engagement platform that specializes in connecting organizations with their audiences through targeted geo-notifications and relevant communications. The company offers two main products: a nudge mobile platform, which facilitates audience engagement via location-based notifications, and Larky Classic, a mobile engagement solution designed to enhance communication with members, support local businesses, and foster loyalty. Additionally, Larky provides a merchant-funded loyalty platform that enables users to receive instant savings at local merchants. Larky serves a diverse client base, including financial institutions, health insurance providers, universities, and media companies across the United States and Canada. Founded in 2011 and headquartered in Ann Arbor, Michigan, Larky was previously known as PerkPerk, Inc.
VNN
Series A in 2014
VNN, Inc. operates a prominent high school sports marketing and networking platform that serves as a digital hub for athletes, coaches, and fans. The platform enables athletes to upload videos, photos, stories, and scores, while allowing coaches to report game results to various media outlets. VNN is dedicated to enhancing the experience of high school sports by aggregating the fragmented market and providing advertising and promotional services. The company has established a significant presence, serving schools across multiple states, including Alabama, California, and Texas, and has gained a rapidly growing user base, with over 7 million fans engaging with the platform daily. Founded in 2010 and based in Grand Rapids, Michigan, VNN aims to transform the consumer experience in high school sports by leveraging technology and connectivity.
Delphinus Medical Technologies
Series B in 2013
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
Waymark (formerly Stik)
Series A in 2013
We’re on a mission. At Waymark, we believe great video should be accessible to everyone and we’re building the tools to make that a reality. Whether you're a brand, enterprise, media platform, agency, or even a small business, Waymark’s anyone-can-edit video technology makes it easy to scale video and accelerate your business. With Waymark, anyone can make beautiful videos effortlessly. No creativity required. We’re a team of tenacious people who don’t take no for an answer and live at the intersection of design and technology. We launched Waymark in 2017 and have been building it with care ever since.
Larky
Seed Round in 2012
Larky, Inc. is a marketing and engagement platform that specializes in connecting organizations with their audiences through targeted geo-notifications and relevant communications. The company offers two main products: a nudge mobile platform, which facilitates audience engagement via location-based notifications, and Larky Classic, a mobile engagement solution designed to enhance communication with members, support local businesses, and foster loyalty. Additionally, Larky provides a merchant-funded loyalty platform that enables users to receive instant savings at local merchants. Larky serves a diverse client base, including financial institutions, health insurance providers, universities, and media companies across the United States and Canada. Founded in 2011 and headquartered in Ann Arbor, Michigan, Larky was previously known as PerkPerk, Inc.
Livio Radio
Series C in 2012
Livio Radio, operating under Myine Electronics, LLC, specializes in designing and manufacturing electronic audio products. Founded in 2008 and based in Ferndale, Michigan, the company offers a range of Bluetooth Internet radio car kits compatible with iPhones and Android devices, as well as car audio players tailored for both personal and commercial use. In addition to its hardware offerings, Livio Radio provides the Livio Connect API, a middleware framework that facilitates the connection and interaction between hardware and various mobile applications. Its products are distributed through retailers, resellers, and online platforms, ensuring accessibility for a wide audience.
CytoPherx
Series C in 2012
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Delphinus Medical Technologies
Series A in 2010
Delphinus Medical Technologies, Inc. is a medical imaging company based in Plymouth, Michigan, with a satellite office in Sunnyvale, California. Founded in 2009, the company specializes in developing and commercializing SoftVue, an innovative ultrasound technology designed for comprehensive breast imaging. This circular array transducer system provides three-dimensional and tomographic imaging, allowing for the examination of women's breasts to detect both benign and malignant masses, assess breast cancer risks, diagnose breast diseases, and monitor treatment. Delphinus serves hospitals and imaging clinics across the United States and internationally, offering a non-invasive, radiation-free solution that enhances the early detection of breast cancer while prioritizing patient comfort.
CytoPherx
Series A in 2007
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
RenaMed Biologics
Venture Round in 2006
RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizes physiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island.
Arbortext
Venture Round in 2003
Arbortext is a software company based in Ann Arbor, Michigan, founded in December 1982. It specializes in XML-based authoring and publishing tools that facilitate the creation, editing, and distribution of content across various multichannel platforms. Arbortext's solutions enable organizations to efficiently manage and publish extensive information in multiple languages and formats, catering to diverse electronic output needs. The company was acquired by Parametric Technology, further enhancing its capabilities in the enterprise software market.
NTT Global Networks
Series B in 2001
NTT Global Networks provides telecommunications services. They offer a cloud framework to automatically activate and configure virtualized IT cloud services for branch offices.
ONE (Open Networks Engineering)
Series A in 2000
ONE is an industry leader in convergence management technology—offering comprehensive, web-based solutions for network management. With a thorough understanding of industry needs, their solutions offer ONE access point to a world of converging technology. ONE believes that to effectively manage the convergence of the services and technologies defining the networks of today and tomorrow, management systems and management applications must also converge. Their vision is the creation of a convergence management layer in the network where applications that manage services and equipment can work together seamlessly and can evolve and scale as does the network. Their mission is to make convergence management a reality for their clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.